XU9-18173-99509 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-14
Dose 1 — Pfizer-BioNTech
2021-01-19
Registered in v-safe
2021-01-19
Survey response — days 1–6 daily, dose 1
MedDRA: Arthralgia, Pain in extremity, Self-medication — Feeling: Good · Site: Pain, Swelling · Joint pains · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-01-22
Survey response — 7 day, dose 1
MedDRA: Headache, Self-medication — Feeling: Fair · Headache, Diarrhea

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-01-28
Health check-in — 14 day, dose 1
Feeling: Good

Adult check-in
2021-02-04
Health check-in — 21 day, dose 1
Feeling: Good

Adult check-in
2021-02-06
Dose 2 — Pfizer-BioNTech
2021-02-07
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-02-08
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site induration, Injection site mass, Injection site pain, Pain, Pyrexia — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-02-11
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site mass — Feeling: Good · Site: Swelling · Fatigue or tiredness · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-02-12
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site mass, Injection site pain — Feeling: Good · Site: Pain · Fatigue or tiredness, Diarrhea

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-02-13
Health check-in — 7 day, dose 2
Feeling: Good · Headache, Diarrhea

Adult check-in
2021-02-20
Health check-in — 14 day, dose 2
Feeling: Good

Adult check-in
2021-02-27
Survey response — 21 day, dose 2
MedDRA: Asthenia, Vision blurred — Feeling: Fair

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-03-06
Health check-in — 28 day, dose 2
Feeling: Good

Adult check-in
2021-03-13
Survey response — 35 day, dose 2
MedDRA: Vision blurred, Visual impairment — Feeling: Good

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-03-20
Health check-in — 42 day, dose 2
Feeling: Good

Adult check-in
2021-05-08
Health check-in — 3 month, dose 2
Feeling: Good

Adult check-in
2021-08-07
Survey response — 6 month, dose 2
MedDRA: Fatigue, Lymphadenopathy — Feeling: Good · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2024-11 · check-in answers available
2022-02-07
Health check-in — 12 month, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-14	Pfizer-BioNTech
2	2021-02-06	Pfizer-BioNTech

Free text

Release 2

Systemic reaction (other): At 24/36 hour after shot severe arm pain took tylenol and had joint pain

Systemic reaction (other): Headache that is relieved with tylenol. I would say for the last 2 days off and on.

Release 3

Systemic reaction (other): Fever concerned me , lump at injection site was is hard and painful

Release 4

Systemic reaction (other): Small lump deep at the injection site. Size of a marble shrinking everyday

Systemic reaction (other): Injection site tender lump is gone.

Symptoms: Energy level is very low, having vision issues. Not sure if blurred vision is an issue

Release 5

Symptoms: Vision is still off, I have spells of blurred vision.

Release 9

Symptoms: I have had swollen lymph nodes in neck, fatigue but no fever. This lasted a bout 3 days. Was not tested for Covid.

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Asthenia	✓	✓	✓
SD	Fatigue	✓	·	✓
SD	Lymphadenopathy	✓	·	✓
SD	Vision blurred	✓	✓	✓
SD	Visual impairment	✓	✓	✓
SRO	Arthralgia	✓	✓	✓
SRO	Headache	✓	✓	✓
SRO	Injection site induration	·	·	✓
SRO	Injection site mass	✓	✓	✓
SRO	Injection site pain	✓	✓	✓
SRO	Pain	✓	✓	○
SRO	Pain in extremity	✓	✓	✓
SRO	Pyrexia	✓	✓	✓
SRO	Self-medication	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release